Compare PROF & KINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PROF | KINS |
|---|---|---|
| Founded | N/A | 1886 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 247.5M | 291.4M |
| IPO Year | 2017 | 2013 |
| Metric | PROF | KINS |
|---|---|---|
| Price | $6.80 | $19.77 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 75.8K | ★ 142.8K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.18% |
| EPS Growth | 25.89 | ★ 94.59 |
| EPS | ★ 0.19 | N/A |
| Revenue | $16,098,000.00 | ★ $214,867,301.00 |
| Revenue This Year | $92.40 | $24.23 |
| Revenue Next Year | $64.10 | $18.05 |
| P/E Ratio | $36.63 | ★ N/A |
| Revenue Growth | ★ 50.73 | 38.50 |
| 52 Week Low | $3.92 | $13.08 |
| 52 Week High | $8.95 | $20.79 |
| Indicator | PROF | KINS |
|---|---|---|
| Relative Strength Index (RSI) | 47.19 | 62.31 |
| Support Level | $6.43 | $14.36 |
| Resistance Level | $7.06 | $20.79 |
| Average True Range (ATR) | 0.38 | 0.72 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 31.75 | 72.55 |
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
Kingstone Companies Inc offers property and casualty insurance products through its subsidiary engaged in writing business through retail and wholesale agents and brokers. Its products include Personal lines, Livery physical damage, and Others. It operates in single segment, property and casualty insurance. It derives substantially all of its revenue from KICO, including revenues from earned premiums, ceding commissions from quota share reinsurance, net investment income generated from its investment portfolio, and net realized gains and losses on investment securities.